Guangdong Jiaying Pharmaceutical Co., Ltd
SZSE:002198.SZ
6.3 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 533.233 | 659.196 | 574.713 | 544.729 | 500.504 | 536.984 | 468.081 | 449.951 | 475.805 | 565.82 | 226.745 | 104.473 | 85.913 | 75.247 | 62.332 | 66.345 | 64.581 | 62.67 | 54.348 | 37.46 |
Cost of Revenue
| 185.513 | 228.528 | 141.905 | 146.535 | 106.38 | 144.004 | 125.034 | 104.733 | 126.708 | 221.252 | 96.79 | 52.104 | 45.082 | 34.204 | 25.828 | 26.864 | 23.863 | 24.088 | 24.637 | 21.981 |
Gross Profit
| 347.72 | 430.667 | 432.809 | 398.194 | 394.124 | 392.979 | 343.047 | 345.217 | 349.097 | 344.568 | 129.954 | 52.369 | 40.831 | 41.043 | 36.505 | 39.482 | 40.717 | 38.583 | 29.711 | 15.479 |
Gross Profit Ratio
| 0.652 | 0.653 | 0.753 | 0.731 | 0.787 | 0.732 | 0.733 | 0.767 | 0.734 | 0.609 | 0.573 | 0.501 | 0.475 | 0.545 | 0.586 | 0.595 | 0.63 | 0.616 | 0.547 | 0.413 |
Reseach & Development Expenses
| 10.098 | 15.34 | 14.401 | 9.378 | 14.353 | 12.407 | 10.108 | 11.202 | 12.23 | 15.245 | 2.045 | 0 | 0.051 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 13.957 | 12.453 | 14.198 | 13.005 | 17.124 | 12.587 | 11.911 | 13.136 | 13.046 | 12.121 | 10.235 | 6.548 | 6.348 | 16.764 | 15.181 | 12.673 | 7.392 | 6.122 | 6.41 | 6.455 |
Selling & Marketing Expenses
| 244.765 | 307.439 | 328.341 | 299.909 | 306.061 | 275.67 | 235.285 | 202.538 | 210.349 | 198.769 | 66.684 | 37.642 | 17.526 | 19.095 | 12.772 | 13.912 | 7.131 | 7.978 | 6.45 | 5.507 |
SG&A
| 258.722 | 319.893 | 342.539 | 312.914 | 323.185 | 288.257 | 247.196 | 215.674 | 223.395 | 210.89 | 76.919 | 44.191 | 23.874 | 35.859 | 27.954 | 26.585 | 14.523 | 14.101 | 12.86 | 11.962 |
Other Expenses
| -1.142 | 40.733 | 46.285 | 42.865 | 47.111 | 0.493 | 1.079 | -0.031 | 3.935 | 11.441 | 4.007 | 2.008 | 1.219 | 3.513 | 2.75 | 2.583 | 6.371 | 1.634 | 0.503 | 0.521 |
Operating Expenses
| 310.41 | 375.965 | 403.225 | 365.157 | 384.649 | 346.086 | 304.572 | 274.48 | 274.228 | 263.067 | 101.165 | 62.028 | 40.684 | 36.784 | 28.59 | 27.355 | 15.278 | 14.868 | 13.487 | 12.265 |
Operating Income
| 40.515 | 53.884 | 33.643 | 24.053 | 8.943 | 41.839 | -206.909 | 66.686 | 74.448 | 76.181 | 176.344 | 5.04 | 19.627 | 22.678 | 14.025 | 12.745 | 23.704 | 23.108 | 15.503 | 2.844 |
Operating Income Ratio
| 0.076 | 0.082 | 0.059 | 0.044 | 0.018 | 0.078 | -0.442 | 0.148 | 0.156 | 0.135 | 0.778 | 0.048 | 0.228 | 0.301 | 0.225 | 0.192 | 0.367 | 0.369 | 0.285 | 0.076 |
Total Other Income Expenses Net
| 2.063 | -2.787 | -27.82 | -1.031 | -123.124 | -4.561 | -244.305 | -4.112 | 3.363 | 5.806 | 150.532 | 16.707 | 20.699 | 21.932 | 8.861 | 3.937 | 3.331 | 0.894 | -0.781 | -0.37 |
Income Before Tax
| 39.374 | 51.097 | 5.823 | 23.022 | -114.181 | 42.331 | -205.83 | 66.626 | 78.233 | 87.307 | 179.322 | 7.048 | 20.846 | 26.191 | 16.775 | 16.063 | 28.771 | 24.608 | 15.443 | 2.844 |
Income Before Tax Ratio
| 0.074 | 0.078 | 0.01 | 0.042 | -0.228 | 0.079 | -0.44 | 0.148 | 0.164 | 0.154 | 0.791 | 0.067 | 0.243 | 0.348 | 0.269 | 0.242 | 0.446 | 0.393 | 0.284 | 0.076 |
Income Tax Expense
| 5.053 | 7.163 | 4.346 | 3.184 | 8.004 | 6.453 | 8.932 | 11.454 | 11.878 | 13.653 | 39.832 | -0.52 | 0.607 | 0.944 | 1.696 | 2.342 | 4.352 | 2.495 | 0.025 | 0.075 |
Net Income
| 34.32 | 43.935 | 1.477 | 19.838 | -122.184 | 35.879 | -214.762 | 55.172 | 66.355 | 73.654 | 139.491 | 7.568 | 20.239 | 25.247 | 15.079 | 13.721 | 24.419 | 22.113 | 15.419 | 2.769 |
Net Income Ratio
| 0.064 | 0.067 | 0.003 | 0.036 | -0.244 | 0.067 | -0.459 | 0.123 | 0.139 | 0.13 | 0.615 | 0.072 | 0.236 | 0.336 | 0.242 | 0.207 | 0.378 | 0.353 | 0.284 | 0.074 |
EPS
| 0.068 | 0.087 | 0.003 | 0.039 | -0.24 | 0.071 | -0.42 | 0.11 | 0.13 | 0.15 | 0.33 | 0.019 | 0.049 | 0.062 | 0.036 | 0.034 | 0.08 | 0.072 | 0.05 | 0.01 |
EPS Diluted
| 0.068 | 0.087 | 0.003 | 0.039 | -0.24 | 0.071 | -0.42 | 0.11 | 0.13 | 0.15 | 0.33 | 0.019 | 0.049 | 0.062 | 0.036 | 0.034 | 0.08 | 0.072 | 0.05 | 0.01 |
EBITDA
| 63.05 | 80.513 | 62.04 | 57.574 | 36.12 | 76.32 | 67.067 | 98.676 | 102.315 | 116.609 | 201.539 | 23.958 | 37.796 | 39.218 | 23.888 | 23.015 | 36.069 | 29.708 | 20.347 | 5.21 |
EBITDA Ratio
| 0.118 | 0.122 | 0.108 | 0.106 | 0.072 | 0.142 | 0.143 | 0.219 | 0.215 | 0.206 | 0.889 | 0.229 | 0.44 | 0.521 | 0.383 | 0.347 | 0.559 | 0.474 | 0.374 | 0.139 |